Corrigendum to “Characterizing the Metabolites of the Tyrosine-Kinase Inhibitor Pexidartinib in Mouse Feces, Urine, Plasma, and Liver” [J. Pharm. Biomed. Anal. 265 (2025) 117034]

Authors

• Xuan Qin
• Si Chen
• John M Hakenjos
• Jian Wang
• Lei Guo
• Ashish Dogra
• Zhaoyong Hu
• Kevin R MacKenzie
• Feng Li

Language

English

Publication Date

10-15-2026

Journal

Journal of Pharmaceutical and Biomedical Analysis

DOI

10.1016/j.jpba.2026.117523

PMID

42140031

Published Open-Access

yes

Recommended Citation

Qin, Xuan; Chen, Si; Hakenjos, John M; et al., "Corrigendum to “Characterizing the Metabolites of the Tyrosine-Kinase Inhibitor Pexidartinib in Mouse Feces, Urine, Plasma, and Liver” [J. Pharm. Biomed. Anal. 265 (2025) 117034]" (2026). Faculty, Staff and Students Publications. 7479.
https://digitalcommons.library.tmc.edu/baylor_docs/7479